RVC Seed Fund (RVC SF) in joined effort with the Science Park of Lomonosov Moscow State University has created ACP Seed Fund Investment Partnership. The new microfoundation is to finance projects of leading Moscow universities and research centers in the field of industrial technology
Biometric identification algorithms by Sonda Technologies has shown the fourth result in the test, conducted by the National Institute of Standards and Technology (NIST). The company' algorithms has shown high identification accuracy and speed of comparisons with significant savings on computing resources
On March 12-13, the practical forum "Ecosystem of Innovation - Universities and Research Centers" will be held in the National University of Science and Technology "MISIS", where representatives of universities, research organizations, and corporations will discuss certain steps towards implementation of university-to-industry projects
In 2014, the key activity of RVC was to ensure a balanced sectorial and industrial structure of Russian venture capital market in accordance with the earlier adopted "RVC OJSC Strategy" (2020) and "RVC OJSC Development Strategy 2014-2016"
On December 23-24, RVC took part in the Conference for Eurasian Cooperation held in Harbin and organized by China's largest development institution - Torch High Technology Industry Development Center, Ministry of Science and Technology of the People's Republic of China
RVC Seed Fund together with Scientific integration Company and two private investors (attracted via IPOboard online trading system) signed an agreement on financing of the WiseSoil project. The total amount of the investments in the project is 20 million rubles
"Ecosystem of innovations" – Forum on the development of regional innovation infrastructure was held on December 4-5, 2014 in Krasnaya Polyana. Over 300 representatives of government authorities, innovation clusters, technology parks, universities, regional venture capital funds and high-tech companies attended the Forum
RVC and the Government of the Republic of Tatarstan signed an agreement on cooperation in the field of innovation activity and a roadmap for cooperation in the field of development of venture capital infrastructure of the region in the 2015-2019. The documents were signed by Igor Agamirzyan, CEO, Chairman of the Management Board of RVC and Ildar Khalikov, Prime Minister of the Republic of Tatarstan
The biggest in the history of Russia Third Week of Business Angels is coming to an end. More than 70 events: roundtables, panel discussions, forums and workshops on the subject of the development of early stages venture capital market, were held in 25 regions of Russia
Opening of the first Russian laboratory for the production of antibodies for the diagnosis of cancer and the development of diagnostic systems based on them - PraymBioMed, - took place on December 4 in the "Slava" tech park
The volume of transactions with the participation of private investors of an early stage in 2014 amounted to $ 34.3 million., which is about one third more than in 2012 and 40% lower than in 2013 – data of the annual Russian business angels market research by Atom Partners, RVC and the National Association of Business Angels was presented in Skolkovo Hypercube on November 25 within the framework of the 5th Annual NBBA Congress
On November 19, 2014 the event-hall InfoProstranstvo hosted the 2nd Corporate Venture Summit held by the Innovation and R&D Directors Club (iR&D Club) with the support of the Russian Venture Company (RVC). The Summit is organized for the two consecutive years as part of an iR&D Club and RVC co-project aimed at the development of the Russian market of corporate venture investments.
With the methodological support of RVC in the Sverdlovsk region there was created Regional Venture Fund (SVF) whose goal is to develop the infrastructure of venture financing of small innovative enterprises in the region. The size of the fund amounts to 156 million rubles. The distinctive feature of the new structure from the venture capital funds previously operated in the region is the opportunity to invest in portfolio companies directly, without creating a CEIF
From October 24 till October 27 RVC delegation together with representatives of the Ministry of Economic Development and the Ministry of Education of Russia, Skolkovo Foundation and members of academic and business communities of Russia took part in the Russian week in China, which included the Chinese-Russian Conference "Innovations - the key to cooperation" and VII Pujiang International Innovation Forum
Osteros Biomedica Ltd., a joint venture company of Maxwell Biotech Group and MBC Pharma Inc., and formed with the participation of Russian Venture Company announced today that the first cohort of patients has been dosed in a phase 1 study of its drug MBC-11 in patients with cancer-induced bone disease